Drug interactions
Glucagon intranasal + Indacaterol-glycopyrronium
Severity: Minor
Glucagon intranasal and Indacaterol-glycopyrronium: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Glucagon inhibits gastrointestinal motility, and anticholinergics such as glycopyrronium do likewise. Inhaled glycopyrronium has low systemic exposure, so the additive effect is usually small and occasional use of nasal glucagon for hypoglycemia is rarely affected.
What this interaction means in plain words
Glucagon intranasal and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive inhibition of gastrointestinal motility through glucagon and anticholinergic effects.
What to do
No change is generally needed; give glucagon as required in hypoglycemia. Watch for abdominal distension or constipation if gastrointestinal symptoms develop.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glucagon intranasal and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Frequently asked questions
Can I take Glucagon intranasal with Indacaterol-glycopyrronium?
MediHelp rates the interaction as minor. Glucagon intranasal and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Glucagon inhibits gastrointestinal motility, and anticholinergics such as glycopyrronium do likewise. Inhaled glycopyrronium has low systemic exposure, so the additive effect is usually small and occasional use of nasal glucagon for hypoglycemia is rarely affected.
How serious is the interaction between Glucagon intranasal and Indacaterol-glycopyrronium?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No change is generally needed; give glucagon as required in hypoglycemia. Watch for abdominal distension or constipation if gastrointestinal symptoms develop.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
